Global Neurostimulation Devices Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	182 Pages	TechNavio	October, 2024	INF19287104

Best Price Guarantee
Price	from $2,500
Length	182 Pages
Publisher	TechNavio
Published Date	October, 2024
SKU	INF19287104

Neurostimulation Devices Market 2024-2028

The neurostimulation devices market is forecasted to grow by USD 7289.3 mn during 2023-2028, accelerating at a CAGR of 12.7% during the forecast period. The report on the neurostimulation devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of neurological disorders, increasing number of initiatives to increase awareness of and access to neurological healthcare, and rapid increase in geriatric population.

Technavio's neurostimulation devices market is segmented as below:

By Product
Implantable neurostimulation devices
External neurostimulation devices
By Application
Pain management
Urinary and fecal incontinence
Parkinsons disease
Epilepsy
Others
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)

This study identifies the expanding indications of neurostimulation devices as one of the prime reasons driving the neurostimulation devices market growth during the next few years. Also, increasing number of initiatives supporting research related to neurostimulation technology and technological advances in neurostimulation devices will lead to sizable demand in the market.

The report on the neurostimulation devices market covers the following areas:

Neurostimulation Devices Market sizing
Neurostimulation Devices Market forecast
Neurostimulation Devices Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neurostimulation devices market vendors that include Abbott Laboratories, ALEVA NEUROTHERAPEUTICS SA, Axonics Inc., Bayer AG, Bioinduction Ltd, Boston Scientific Corp., electroCore Inc., EndoStim Inc, Integer Holdings Corp., Laborie, LivaNova PLC, Medtronic Plc, NeuroMetrix Inc., NEURONETICS Inc., NeuroPace Inc., Nevro Corp., Parasym, Perflow Medical Ltd., Soterix Medical Inc., and Synapse Biomedical Inc.. Also, the neurostimulation devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Neurostimulation Devices Market 2018 - 2022; Historic Market Size - Data Table on Global Neurostimulation Devices Market 2018 - 2022 ($ million); 4.2 Product segment analysis 2018 - 2022; Historic Market Size - Product Segment 2018 - 2022 ($ million); 4.3 Application segment analysis 2018 - 2022; Historic Market Size - Application Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product: 6.1 Market segments; Chart on Product - Market share 2023-2028 (%); Data Table on Product - Market share 2023-2028 (%); 6.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 6.3 Implantable neurostimulation devices - Market size and forecast 2023-2028; Chart on Implantable neurostimulation devices - Market size and forecast 2023-2028 ($ million); Data Table on Implantable neurostimulation devices - Market size and forecast 2023-2028 ($ million); Chart on Implantable neurostimulation devices - Year-over-year growth 2023-2028 (%); Data Table on Implantable neurostimulation devices - Year-over-year growth 2023-2028 (%); 6.4 External neurostimulation devices - Market size and forecast 2023-2028; Chart on External neurostimulation devices - Market size and forecast 2023-2028 ($ million); Data Table on External neurostimulation devices - Market size and forecast 2023-2028 ($ million); Chart on External neurostimulation devices - Year-over-year growth 2023-2028 (%); Data Table on External neurostimulation devices - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Product; Market opportunity by Product ($ million); Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Application: 7.1 Market segments; Chart on Application - Market share 2023-2028 (%); Data Table on Application - Market share 2023-2028 (%); 7.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 7.3 Pain management - Market size and forecast 2023-2028; Chart on Pain management - Market size and forecast 2023-2028 ($ million); Data Table on Pain management - Market size and forecast 2023-2028 ($ million); Chart on Pain management - Year-over-year growth 2023-2028 (%); Data Table on Pain management - Year-over-year growth 2023-2028 (%); 7.4 Urinary and fecal incontinence - Market size and forecast 2023-2028; Chart on Urinary and fecal incontinence - Market size and forecast 2023-2028 ($ million); Data Table on Urinary and fecal incontinence - Market size and forecast 2023-2028 ($ million); Chart on Urinary and fecal incontinence - Year-over-year growth 2023-2028 (%); Data Table on Urinary and fecal incontinence - Year-over-year growth 2023-2028 (%); 7.5 Parkinsons disease - Market size and forecast 2023-2028; Chart on Parkinsons disease - Market size and forecast 2023-2028 ($ million); Data Table on Parkinsons disease - Market size and forecast 2023-2028 ($ million); Chart on Parkinsons disease - Year-over-year growth 2023-2028 (%); Data Table on Parkinsons disease - Year-over-year growth 2023-2028 (%); 7.6 Epilepsy - Market size and forecast 2023-2028; Chart on Epilepsy - Market size and forecast 2023-2028 ($ million); Data Table on Epilepsy - Market size and forecast 2023-2028 ($ million); Chart on Epilepsy - Year-over-year growth 2023-2028 (%); Data Table on Epilepsy - Year-over-year growth 2023-2028 (%); 7.7 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ million); Data Table on Others - Market size and forecast 2023-2028 ($ million); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 7.8 Market opportunity by Application; Market opportunity by Application ($ million); Data Table on Market opportunity by Application ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.9 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.10 Japan - Market size and forecast 2023-2028; Chart on Japan - Market size and forecast 2023-2028 ($ million); Data Table on Japan - Market size and forecast 2023-2028 ($ million); Chart on Japan - Year-over-year growth 2023-2028 (%); Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.11 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 Abbott Laboratories; Abbott Laboratories - Overview; Abbott Laboratories - Business segments; Abbott Laboratories - Key news; Abbott Laboratories - Key offerings; Abbott Laboratories - Segment focus; 12.4 ALEVA NEUROTHERAPEUTICS SA; ALEVA NEUROTHERAPEUTICS SA - Overview; ALEVA NEUROTHERAPEUTICS SA - Product / Service; ALEVA NEUROTHERAPEUTICS SA - Key offerings; 12.5 Bayer AG; Bayer AG - Overview; Bayer AG - Business segments; Bayer AG - Key news; Bayer AG - Key offerings; Bayer AG - Segment focus; 12.6 Boston Scientific Corp.; Boston Scientific Corp. - Overview; Boston Scientific Corp. - Business segments; Boston Scientific Corp. - Key news; Boston Scientific Corp. - Key offerings; Boston Scientific Corp. - Segment focus; 12.7 electroCore Inc.; electroCore Inc. - Overview; electroCore Inc. - Product / Service; electroCore Inc. - Key offerings; 12.8 EndoStim Inc; EndoStim Inc - Overview; EndoStim Inc - Product / Service; EndoStim Inc - Key offerings; 12.9 Laborie; Laborie - Overview; Laborie - Product / Service; Laborie - Key news; Laborie - Key offerings; 12.10 LivaNova PLC; LivaNova PLC - Overview; LivaNova PLC - Business segments; LivaNova PLC - Key news; LivaNova PLC - Key offerings; LivaNova PLC - Segment focus; 12.11 Medtronic Plc; Medtronic Plc - Overview; Medtronic Plc - Business segments; Medtronic Plc - Key news; Medtronic Plc - Key offerings; Medtronic Plc - Segment focus; 12.12 NeuroMetrix Inc.; NeuroMetrix Inc. - Overview; NeuroMetrix Inc. - Product / Service; NeuroMetrix Inc. - Key offerings; 12.13 NEURONETICS Inc.; NEURONETICS Inc. - Overview; NEURONETICS Inc. - Product / Service; NEURONETICS Inc. - Key offerings; 12.14 NeuroPace Inc.; NeuroPace Inc. - Overview; NeuroPace Inc. - Product / Service; NeuroPace Inc. - Key offerings; 12.15 Nevro Corp.; Nevro Corp. - Overview; Nevro Corp. - Product / Service; Nevro Corp. - Key offerings; 12.16 Soterix Medical Inc.; Soterix Medical Inc. - Overview; Soterix Medical Inc. - Product / Service; Soterix Medical Inc. - Key offerings; 12.17 Synapse Biomedical Inc.; Synapse Biomedical Inc. - Overview; Synapse Biomedical Inc. - Product / Service; Synapse Biomedical Inc. - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Product; Exhibits6: Executive Summary - Chart on Market Segmentation by Application; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Neurostimulation Devices Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Product Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Application Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Product - Market share 2023-2028 (%); Exhibits33: Data Table on Product - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Product; Exhibits35: Data Table on Comparison by Product; Exhibits36: Chart on Implantable neurostimulation devices - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Implantable neurostimulation devices - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Implantable neurostimulation devices - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Implantable neurostimulation devices - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on External neurostimulation devices - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on External neurostimulation devices - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on External neurostimulation devices - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on External neurostimulation devices - Year-over-year growth 2023-2028 (%); Exhibits44: Market opportunity by Product ($ million); Exhibits45: Data Table on Market opportunity by Product ($ million); Exhibits46: Chart on Application - Market share 2023-2028 (%); Exhibits47: Data Table on Application - Market share 2023-2028 (%); Exhibits48: Chart on Comparison by Application; Exhibits49: Data Table on Comparison by Application; Exhibits50: Chart on Pain management - Market size and forecast 2023-2028 ($ million); Exhibits51: Data Table on Pain management - Market size and forecast 2023-2028 ($ million); Exhibits52: Chart on Pain management - Year-over-year growth 2023-2028 (%); Exhibits53: Data Table on Pain management - Year-over-year growth 2023-2028 (%); Exhibits54: Chart on Urinary and fecal incontinence - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Urinary and fecal incontinence - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Urinary and fecal incontinence - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Urinary and fecal incontinence - Year-over-year growth 2023-2028 (%); Exhibits58: Chart on Parkinsons disease - Market size and forecast 2023-2028 ($ million); Exhibits59: Data Table on Parkinsons disease - Market size and forecast 2023-2028 ($ million); Exhibits60: Chart on Parkinsons disease - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on Parkinsons disease - Year-over-year growth 2023-2028 (%); Exhibits62: Chart on Epilepsy - Market size and forecast 2023-2028 ($ million); Exhibits63: Data Table on Epilepsy - Market size and forecast 2023-2028 ($ million); Exhibits64: Chart on Epilepsy - Year-over-year growth 2023-2028 (%); Exhibits65: Data Table on Epilepsy - Year-over-year growth 2023-2028 (%); Exhibits66: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits67: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits68: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits69: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits70: Market opportunity by Application ($ million); Exhibits71: Data Table on Market opportunity by Application ($ million); Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits73: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits74: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits75: Chart on Geographic comparison; Exhibits76: Data Table on Geographic comparison; Exhibits77: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits102: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits103: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits105: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits106: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits107: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits108: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits109: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits110: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits111: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits112: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits113: Market opportunity By Geographical Landscape ($ million); Exhibits114: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits115: Impact of drivers and challenges in 2023 and 2028; Exhibits116: Overview on criticality of inputs and factors of differentiation; Exhibits117: Overview on factors of disruption; Exhibits118: Impact of key risks on business; Exhibits119: Companies covered; Exhibits120: Matrix on companies position and classification; Exhibits121: Abbott Laboratories - Overview; Exhibits122: Abbott Laboratories - Business segments; Exhibits123: Abbott Laboratories - Key news; Exhibits124: Abbott Laboratories - Key offerings; Exhibits125: Abbott Laboratories - Segment focus; Exhibits126: ALEVA NEUROTHERAPEUTICS SA - Overview; Exhibits127: ALEVA NEUROTHERAPEUTICS SA - Product / Service; Exhibits128: ALEVA NEUROTHERAPEUTICS SA - Key offerings; Exhibits129: Bayer AG - Overview; Exhibits130: Bayer AG - Business segments; Exhibits131: Bayer AG - Key news; Exhibits132: Bayer AG - Key offerings; Exhibits133: Bayer AG - Segment focus; Exhibits134: Boston Scientific Corp. - Overview; Exhibits135: Boston Scientific Corp. - Business segments; Exhibits136: Boston Scientific Corp. - Key news; Exhibits137: Boston Scientific Corp. - Key offerings; Exhibits138: Boston Scientific Corp. - Segment focus; Exhibits139: electroCore Inc. - Overview; Exhibits140: electroCore Inc. - Product / Service; Exhibits141: electroCore Inc. - Key offerings; Exhibits142: EndoStim Inc - Overview; Exhibits143: EndoStim Inc - Product / Service; Exhibits144: EndoStim Inc - Key offerings; Exhibits145: Laborie - Overview; Exhibits146: Laborie - Product / Service; Exhibits147: Laborie - Key news; Exhibits148: Laborie - Key offerings; Exhibits149: LivaNova PLC - Overview; Exhibits150: LivaNova PLC - Business segments; Exhibits151: LivaNova PLC - Key news; Exhibits152: LivaNova PLC - Key offerings; Exhibits153: LivaNova PLC - Segment focus; Exhibits154: Medtronic Plc - Overview; Exhibits155: Medtronic Plc - Business segments; Exhibits156: Medtronic Plc - Key news; Exhibits157: Medtronic Plc - Key offerings; Exhibits158: Medtronic Plc - Segment focus; Exhibits159: NeuroMetrix Inc. - Overview; Exhibits160: NeuroMetrix Inc. - Product / Service; Exhibits161: NeuroMetrix Inc. - Key offerings; Exhibits162: NEURONETICS Inc. - Overview; Exhibits163: NEURONETICS Inc. - Product / Service; Exhibits164: NEURONETICS Inc. - Key offerings; Exhibits165: NeuroPace Inc. - Overview; Exhibits166: NeuroPace Inc. - Product / Service; Exhibits167: NeuroPace Inc. - Key offerings; Exhibits168: Nevro Corp. - Overview; Exhibits169: Nevro Corp. - Product / Service; Exhibits170: Nevro Corp. - Key offerings; Exhibits171: Soterix Medical Inc. - Overview; Exhibits172: Soterix Medical Inc. - Product / Service; Exhibits173: Soterix Medical Inc. - Key offerings; Exhibits174: Synapse Biomedical Inc. - Overview; Exhibits175: Synapse Biomedical Inc. - Product / Service; Exhibits176: Synapse Biomedical Inc. - Key offerings; Exhibits177: Inclusions checklist; Exhibits178: Exclusions checklist; Exhibits179: Currency conversion rates for US$; Exhibits180: Research methodology; Exhibits181: Information sources; Exhibits182: Data validation; Exhibits183: Validation techniques employed for market sizing; Exhibits184: Data synthesis; Exhibits185: 360 degree market analysis; Exhibits186: List of abbreviations